Key result
Irx4 interacts with the RXR alpha component of the VDR/RXR alpha heterodimer to form an inhibitory complex that represses slow MyHC3 gene expression in the ventricular chambers.
Population
Preclinical models studying chick/quail homologs of slow MyHC3
Design
Preclinical
Authors
Loading...
May refine chamber-specific gene regulation models; leaves open translational relevance to human cardiogenesis or disease.
The study identifies a novel molecular mechanism where Irx4, VDR, and RXR alpha form an inhibitory complex to restrict slow MyHC3 expression to the atrial chambers during heart development.
Wang et al. (2001) studied Cardiac chamber-specific gene expression. Irx4, VDR, and RXR alpha interaction was evaluated on slow MyHC3 gene expression. Irx4 interacts with the RXR alpha component of the VDR/RXR alpha heterodimer to form an inhibitory complex that represses slow MyHC3 gene expression in the ventricular chambers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: